Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

2020 ◽  
Vol 45 (1) ◽  
pp. 19-31 ◽  
Author(s):  
Madhav Prasad Yadav ◽  
Sanjana Ballal ◽  
Chandrashekhar Bal ◽  
Ranjit Kumar Sahoo ◽  
Nishikant Avinash Damle ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Efficacy And Safety ◽  
Castration Resistant Prostate Cancer ◽  
Radioligand Therapy ◽  
Castration Resistant

scholarly journals Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients

Theranostics ◽  
2020 ◽  
Vol 10 (20) ◽  
pp. 9364-9377 ◽  
Author(s):  
Madhav Prasad Yadav ◽  
Sanjana Ballal ◽  
Ranjit Kumar Sahoo ◽  
Madhavi Tripathi ◽  
Amlesh Seth ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Efficacy And Safety ◽  
Castration Resistant Prostate Cancer ◽  
Targeted Alpha Therapy ◽  
Castration Resistant ◽  
Alpha Therapy

scholarly journals 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney

2019 ◽  
Vol 60 (11) ◽  
pp. 1579-1586 ◽  
Author(s):  
Jingjing Zhang ◽  
Harshad R. Kulkarni ◽  
Aviral Singh ◽  
Christiane Schuchardt ◽  
Karin Niepsch ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Castration Resistant Prostate Cancer ◽  
Radioligand Therapy ◽  
Castration Resistant ◽  
Functioning Kidney

scholarly journals Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy

Oncotarget ◽  
2017 ◽  
Vol 8 (61) ◽  
pp. 103108-103116 ◽  
Author(s):  
Hojjat Ahmadzadehfar ◽  
Stephan Schlolaut ◽  
Rolf Fimmers ◽  
Anna Yordanova ◽  
Stefan Hirzebruch ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Overall Survival ◽  
Cancer Patients ◽  
Castration Resistant Prostate Cancer ◽  
Radioligand Therapy ◽  
Castration Resistant

scholarly journals Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial

2016 ◽  
Vol 70 (5) ◽  
pp. 875-883 ◽  
Author(s):  
Christopher Parker ◽  
Steven E. Finkelstein ◽  
Jeff M. Michalski ◽  
Joe M. O'Sullivan ◽  
Øyvind Bruland ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Efficacy And Safety ◽  
Castration Resistant Prostate Cancer ◽  
Opioid Use ◽  
Phase 3 ◽  
Castration Resistant ◽  
Radium 223
Sign in / Sign up

Export Citation Format

Share Document